Yong Yeup Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yong Yeup Kim has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Jae Bok Lee
Department of Surgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
5 shared publications - Jai Hyun Chung
Department of Surgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
5 shared publications - Sang Uk Woo
Department of Surgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
5 shared publications - Woo Young Kim
Department of Surgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
5 shared publications - Ji Hye Kim
Department of Surgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
4 shared publications - Ye Ryung Kim
Department of Surgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 111 (1) , 20-23
Is breast-conserving surgery feasible for patients with prior breast augmentation?: a single-center retrospective case series
Jang MY, et al. Ann Surg Treat Res. 2026 Jul;111(1):20-23. https://doi.org/10.4174/astr.2026.111.1.20
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 111 (1) , 20-23
Open AccessIs breast-conserving surgery feasible for patients with prior breast augmentation?: a single-center retrospective case series
Jang MY, et al. Ann Surg Treat Res. 2026 Jul;111(1):20-23. https://doi.org/10.4174/astr.2026.111.1.20
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (2) , 112-118
Progesterone receptor expression and its prognostic role in hormone receptor-positive/human epidermal growth factor receptor 2-positive breast cancer: a retrospective cohort study
While progesterone receptor (PR) negativity in luminal-type breast cancer is generally associated with worse oncologic outcomes, its prognostic role in estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-positive breast cancer remains underexplored. This study aimed to evaluate the prognostic significance of PR expression in ER-positive, HER2-positive breast cancer. A retrospective analysis was conducted on patients diagnosed with ER-positive, HER2-positive breast cancer who underwent primary surgery at Korea University Guro Hospital between January 2009 and December 2019. Patients were grouped by PR expression as negative/low (Allred score, 0–6) or strongly positive (Allred score,7 or 8). Prognostic outcomes, including disease-free survival (DFS), distant recurrence-free survival (DRFS), and breast cancer-specific survival (BCSS) were analyzed. A total of 223 patients were included. Patients in the negative/low PR group were older compared to the strongly positive PR group. The negative/low PR group showed significantly worse DFS (P = 0.005) and DRFS (P = 0.014) but showed no significant difference in BCSS (P = 0.153). On multivariate analysis, negative or low PR expressions were linked to inferior DFS (hazard ratio [HR], 3.10; 95% confidence interval [CI], 1.34–7.16; P = 0.008) and DRFS (HR, 9.55; 95% CI, 1.22–74.77; P = 0.032). In ER-positive, HER2-positive breast cancer, negative or weak PR expression was associated with inferior DFS and DRFS compared to strong PR expression. These findings highlight the potential prognostic value of PR status in this group, underscoring its relevance in guiding treatment and follow-up strategies for more individualized patient care.
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (2) , 112-118
Open AccessProgesterone receptor expression and its prognostic role in hormone receptor-positive/human epidermal growth factor receptor 2-positive breast cancer: a retrospective cohort study
While progesterone receptor (PR) negativity in luminal-type breast cancer is generally associated with worse oncologic outcomes, its prognostic role in estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-positive breast cancer remains underexplored. This study aimed to evaluate the prognostic significance of PR expression in ER-positive, HER2-positive breast cancer. A retrospective analysis was conducted on patients diagnosed with ER-positive, HER2-positive breast cancer who underwent primary surgery at Korea University Guro Hospital between January 2009 and December 2019. Patients were grouped by PR expression as negative/low (Allred score, 0–6) or strongly positive (Allred score,7 or 8). Prognostic outcomes, including disease-free survival (DFS), distant recurrence-free survival (DRFS), and breast cancer-specific survival (BCSS) were analyzed. A total of 223 patients were included. Patients in the negative/low PR group were older compared to the strongly positive PR group. The negative/low PR group showed significantly worse DFS (P = 0.005) and DRFS (P = 0.014) but showed no significant difference in BCSS (P = 0.153). On multivariate analysis, negative or low PR expressions were linked to inferior DFS (hazard ratio [HR], 3.10; 95% confidence interval [CI], 1.34–7.16; P = 0.008) and DRFS (HR, 9.55; 95% CI, 1.22–74.77; P = 0.032). In ER-positive, HER2-positive breast cancer, negative or weak PR expression was associated with inferior DFS and DRFS compared to strong PR expression. These findings highlight the potential prognostic value of PR status in this group, underscoring its relevance in guiding treatment and follow-up strategies for more individualized patient care.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Breast Cancer
- Vol. 28 (2) , 99-107
Breast Cancer in Older Patients Aged 70 Years and Above: Treatment Adherence and Oncologic Outcomes
Kim JH, et al. J Breast Cancer. 2025 Feb;28:e8. https://doi.org/10.4048/jbc.2024.0190
- 1 January 2025
- Published by XMLink in Journal of Breast Cancer
- Vol. 28 (2) , 99-107
Open AccessBreast Cancer in Older Patients Aged 70 Years and Above: Treatment Adherence and Oncologic Outcomes
Kim JH, et al. J Breast Cancer. 2025 Feb;28:e8. https://doi.org/10.4048/jbc.2024.0190
- Open Access
- 1 January 2024
- Published by XMLink in Annals of Robotic and Innovative Surgery
- Vol. 5 (1) , 1-9
Trends in Operation Times for Robot-assisted Nipple-sparing Mastectomy Performed by Expert Breast Surgeons
Kim JH, et al. Ann Robot Innov Surg. 2024 May;5(1):1-9. https://doi.org/10.37007/aris.2024.5.1.1
- 1 January 2024
- Published by XMLink in Annals of Robotic and Innovative Surgery
- Vol. 5 (1) , 1-9
Open AccessTrends in Operation Times for Robot-assisted Nipple-sparing Mastectomy Performed by Expert Breast Surgeons
Kim JH, et al. Ann Robot Innov Surg. 2024 May;5(1):1-9. https://doi.org/10.37007/aris.2024.5.1.1
- Open Access
- 1 January 2024
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 106 (4) , 189-194
Safe and successful pregnancy following breast cancer treatment in young patients 35 years old or under without invasive fertility preservation: a retrospective study
Kim JH, et al. Ann Surg Treat Res. 2024 Apr;106(4):189-194. https://doi.org/10.4174/astr.2024.106.4.189
- 1 January 2024
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 106 (4) , 189-194
Open AccessSafe and successful pregnancy following breast cancer treatment in young patients 35 years old or under without invasive fertility preservation: a retrospective study
Kim JH, et al. Ann Surg Treat Res. 2024 Apr;106(4):189-194. https://doi.org/10.4174/astr.2024.106.4.189
- Open Access
- 31 January 2022
- Published by Hindawi Limited in The Breast Journal
- Vol. 2022, 1-6
Under- and Normal-Weight Patients Are More Susceptible to Recurrence of Phyllodes Tumor
Purpose. Phyllodes tumors (PTs) of the breast are rare fibroepithelial neoplasms, and factors associated with the recurrence of PTs are poorly understood. This study sought to identify clinicopathological factors associated with the recurrence of PTs. Method. From January 2009 to December 2019, we identified 100 patients who underwent definitive surgery for PT. Clinicopathological risk factors associated with the recurrence of PT were assessed. Results. The median age of the patients was 44 y (range, 19–62 y), and the median tumor size was 4 cm (0.8–30 cm). At a median follow-up of 26.7 mo (0–103 mo), 22 of the 100 patients experienced local recurrence. In the univariate and multivariate analyses, body mass index ≥ 23 kg/m2 ( = 0.042 in the univariate analysis; = 0.039 in the multivariate analysis), tumor size ≥ 5 cm ( = 0.006 in the univariate analysis; = 0.036 in the multivariate analysis), and the presence of stromal overgrowth ( = 0.032 in the univariate analysis; = 0.040 in the multivariate analysis) were associated with an increased risk of local recurrence. Resection margins and grade were not associated with local recurrence. Conclusion. Normal- or underweight patients and those with larger tumor sizes were more prone to local recurrence. Further larger, multicenter studies with a long-term follow-up are required.
- 31 January 2022
- Published by Hindawi Limited in The Breast Journal
- Vol. 2022, 1-6
Open AccessUnder- and Normal-Weight Patients Are More Susceptible to Recurrence of Phyllodes Tumor
Purpose. Phyllodes tumors (PTs) of the breast are rare fibroepithelial neoplasms, and factors associated with the recurrence of PTs are poorly understood. This study sought to identify clinicopathological factors associated with the recurrence of PTs. Method. From January 2009 to December 2019, we identified 100 patients who underwent definitive surgery for PT. Clinicopathological risk factors associated with the recurrence of PT were assessed. Results. The median age of the patients was 44 y (range, 19–62 y), and the median tumor size was 4 cm (0.8–30 cm). At a median follow-up of 26.7 mo (0–103 mo), 22 of the 100 patients experienced local recurrence. In the univariate and multivariate analyses, body mass index ≥ 23 kg/m2 ( = 0.042 in the univariate analysis; = 0.039 in the multivariate analysis), tumor size ≥ 5 cm ( = 0.006 in the univariate analysis; = 0.036 in the multivariate analysis), and the presence of stromal overgrowth ( = 0.032 in the univariate analysis; = 0.040 in the multivariate analysis) were associated with an increased risk of local recurrence. Resection margins and grade were not associated with local recurrence. Conclusion. Normal- or underweight patients and those with larger tumor sizes were more prone to local recurrence. Further larger, multicenter studies with a long-term follow-up are required.